EarliTec Diagnostics
Agent47Agent Readiness: 47/100. Above median. Measured by StartupHub.ai. Median 41.Trust82Data Trust: 82/100. Top 25%. Measured by StartupHub.ai. Median 61.EarliPoint Health develops a digital health platform for earlier identification and treatment of autism spectrum disorder (ASD) in children.
About
EarliTec Diagnostics provides an FDA-cleared, eye-tracking technology system called EarliPoint® that aids qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children ages 16 months to 95 months. The system captures eye gaze data during video observation to analyze visual attention patterns, generating actionable insights on language, cognition, and social engagement to support early detection and track treatment progress. This technology is for clinician use only, helping them provide timely, informed care and communicate outcomes with families.
Similar companies
MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.
Shares Healthcare, Diagnostics
Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.
Shares Healthcare, MedTech
Software for early detection of autism spectrum disorders in toddlers using eye-tracking technology.
Shares Healthcare, Autism
AI-powered digital health company transforming neurology with oculometrics for diagnostics and clinical development.
Shares Healthcare, Biomarkers
Mon4t develops smartphone-based medical tests for neurological disorders, providing real-time monitoring and feedback to patients and physicians.
Shares Healthcare, HealthTech
Sight Diagnostics develops rapid, accurate, and convenient diagnostic testing solutions, including a complete blood count analyzer.
Shares Healthcare, Diagnostics
Key facts
- Website
- earlipointhealth.com
- Headquarters
- Atlanta, United States
- Founded
- 2019
- Employees
- 38
- Total funding
- $41M (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 2 Apr 2024 | Series B | $22M | Nexus NeuroTech Ventures, Venture Investors |
| 18 Feb 2022 | Series A | $20M | Bernie Marcus |
Tech stack
Detected on earlipointhealth.com, last scanned 18 Oct 2026. Run your own scan
- Frontend
- jQuery
- CMS / Builders
- WordPress
- Accessibility
- UserWay
EarliTec Diagnostics scores 41. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is EarliTec Diagnostics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for EarliTec Diagnostics is 82 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has EarliTec Diagnostics raised?
EarliTec Diagnostics has raised a total of $41M in funding. The most recent round on record is Series B.
How many employees does EarliTec Diagnostics have?
EarliTec Diagnostics has approximately 38 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for EarliTec Diagnostics
